Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer

NCT05327751 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT05327751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05327751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Possible Protective Effect of Celecoxib Against Capecitabine Induced Hand and Foot Syndrome in Patients With Colorectal Cancer
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Unknown status
Start date
April 1, 2022
Completion date
April 1, 2025
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, erythrodysesthesia syndrome, hand and foot syndrome, hfs